A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone

Phase 3TerminatedNCT00052039

InterMune

Overview

Study GIPF-003 is a Phase 3b study designed to define better therapeutic use of IFN-gamma 1b in patients wtih IPF. The study will be conducted primarily in Europe and will enroll 210 patients.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Conditions

Lung Disease Pulmonary Fibrosis

Interventions

interferon-gamma 1bDRUG

This study was terminated prior to enrollment.

azathioprineDRUG

This study was terminated prior to enrollment.

Locations (1)

Ospedale S. Luigi Gonzaga - Regione

Torino, Orbassano, Italy

Outcomes

Primary Outcomes

This study was terminated prior to enrollment.

Time frame: This study was terminated prior to enrollment.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.